Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone-dichloroacetic acid hybrids

Chem Biol Drug Des. 2020 Feb;95(2):248-259. doi: 10.1111/cbdd.13638. Epub 2019 Nov 2.

Abstract

A series of new fluoroquinolone conjugates 8a-g and 9a-f were synthesized via benzotriazole-mediated synthetic approach with good yield and purity. Some of the synthesized analogs exhibited significant antibacterial properties against Escherichia coli and Staphylococcus aureus with potency higher than that of the parent drugs through in vitro standard bioassay procedure (conjugates 8c and 8d reveal antimicrobial properties with potency 1.9, 61.9, 20.7 and 2.4, 37.1, 8.3 folds relative to the parent antibiotic 6 against E. coli, S. aureus, and Enterococcus faecalis, respectively). The observed experimental data were supported by enzymatic DNA gyrase inhibitory property. Developed BMLR-QSAR model validates the observed experimental data and recognizes the parameters responsible for the enhanced antibacterial properties.

Keywords: DNA gyrase; antibacterial; dichloroacetic acid; fluoroquinolone; hybrid conjugates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Dichloroacetic Acid / chemistry
  • Dichloroacetic Acid / pharmacology*
  • Escherichia coli / drug effects
  • Fluoroquinolones / chemistry
  • Fluoroquinolones / pharmacology*
  • Microbial Sensitivity Tests
  • Staphylococcus aureus / drug effects
  • Topoisomerase II Inhibitors / chemical synthesis
  • Topoisomerase II Inhibitors / chemistry
  • Topoisomerase II Inhibitors / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Topoisomerase II Inhibitors
  • Dichloroacetic Acid